ResearchMoz

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-20
No. Of Pages » 105
 Orthobiology is a branch of science that develops bone and tissue replacement materials for skeletal and tissue healing. Orthobiologics has been gaining popularity since it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market. 
   
 The research report on orthobiologics provides...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)
2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Drivers
3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population
3.1.1.2 Surge in sports injuries
3.1.1.3 Surge in the number of orthopedic surgeries
3.1.1.4 Technological advances in bone graft materials to boost market growth
3.1.1.5 Demand for innovative products to bolster the growth of the market
3.1.2 Restraints
3.1.2.1 Lack of Reimbursement
3.1.2.2 Stringent regulatory requirements to restrain market growth
3.1.3 Opportunities
3.1.3.1 Rise in cell based matrices
3.1.3.2 Emerging markets
3.2 Porter’s Five Force Analysis: Global Orthobiologics Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

Chapter 4 Global Orthobiologics Market, by Product
4.1 Overview
4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
4.2 Bone Morphogenetic Proteins
4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)
4.3 Demineralized Bone Matrix (DBM)
4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)
4.4 Synthetic Bone Substitutes
4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)
4.5 Viscosupplementation
4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)
4.6 Allograft
4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)
4.7 Stem Cell Therapy
4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)
4.8 Machined Bones
4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

Chapter 5 Global Orthobiologics Market, by Application
5.1 Overview
5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Spinal Fusion
5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
5.3 Trauma
5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)
5.4 Reconstructive surgery
5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

Chapter 6 Global Orthobiologics Market, by Geography
6.1 Overview
6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

Chapter 7 Global Orthobiologics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Orthobiologics Market
7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Success strategies
8.1.1 Rigorous research and development (R&D) initiatives
8.1.2 Investing in emerging economies
8.2 Barriers to be considered
8.2.1 Significant Cost of Investment

Chapter 9 Company Profiles
9.1 Alphatec Spine, Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Bacterin International, Inc.
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Biomet, Inc.
9.3.1 Business overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Exactech, Inc.
9.5.1 Business Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Globus Medical, Inc.
9.6.1 Business Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Integra LifeSciences Corporation
9.7.1 Business Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Medtronic, Inc.
9.8.1 Business Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 NuVasive, Inc.
9.9.1 Business Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Orthofix Holdings, Inc.
9.10.1 Business Overview
9.10.2 Financial Overview
9.10.3 Products Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Regeneration Technologies, Inc.
9.11.1 Business Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Sanofi
9.12.1 Business Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Stryker Corporation
9.13.1 Business Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Wright Medical Technology, Inc.
9.14.1 Business Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
9.15 Zimmer Holdings, Inc.
9.15.1 Business Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.15.5 Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Orthobiologics: Market Segmentation
FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)
FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market
FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography
FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)
FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)
FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)
FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)
FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)
FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)
FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)
FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)
FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)
FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

Upcoming Reports:

Poland: rye flour market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the rye flour market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the rye flour market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Greece: peas market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the peas market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the peas market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Needle Free Delivery Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Worldwide market for needle free delivery devices is forecasted to grow and reach the value of $5.9 billion by the year 2022 driven by the factors like developments in technology and emergence of new products such as micro needle patches and novel jet injectors. This market is expected to benefit from increasing efficiency of manufacturing processes, and the growth of emerging economies. Developed economies like the U.S. as well as Japan are also expected to witness double digit growth in the sales of needle free delivery devices market.  Needle free delivery...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
China to Invest in UKs Infrastructure Industry
Oct 28, 2014  
As per industry reports, it is expected that in the year 2015, the UK infrastructure will derive benefits from 105 billion pounds of Chinese money. This will involve a host of Chinese machinery suppliers, contractors, and materials producers. The UK government will be spending about half of 225 billion pounds on its own infrastructure. The investors from China will be investing...